US2021330688A1PendingUtilityA1

Oligosaccharides composition for preventing or reducing the risk of metabolic syndrome

49
Assignee: CLASADO RES SERVICES LIMITEDPriority: Jul 5, 2011Filed: Jul 2, 2021Published: Oct 28, 2021
Est. expiryJul 5, 2031(~4.9 yrs left)· nominal 20-yr term from priority
Inventors:Georgios TzortzisJelena Vulevic
A61P 9/10A61K 9/19A61K 9/0053A61K 31/702A61P 3/08A61K 31/7016A61P 31/06A61P 9/00A61P 5/48A61P 3/06A61P 3/10A61P 5/50A61K 9/0095A61P 3/00
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to the use of a galactooligosaccharide composition for preventing or reducing the risk of developing metabolic syndrome.

Claims

exact text as granted — not AI-modified
1 . A composition comprising a mixture of galactooligosaccharides which comprises disaccharides Gal (ßI-3)-Glc; Gal (ßI-3)-Gal; Gal (ßI-6)-Gal; Gal (αI-6)-Gal;
 trisaccharides Gal (ßI-6)-Gal (ßI-4)-Glc; Gal (ßI-3)-Gal (ßI-4)-Glc; tetrasaccharide Gal (ßI-6)-Gal (ßI-6)-Gal (ßI-4)-Glc and pentasaccharide Gal (ßI-6)-Gal (ßI-6)-Gal (ßI-6)-Gal (ßI-4)-Glc for use in a method for preventing or reducing the risk of developing metabolic syndrome. 
 
     
     
         2 .- 14 . (canceled)

Join the waitlist — get patent alerts

Track US2021330688A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.